Search by property
From The Embassy of Good Science
This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.
List of results
- Ignoring substantial safety risks of the study to participants, workers or environment + (VIGOR (Vioxx Gastrointestinal Outcomes Res … VIGOR (Vioxx Gastrointestinal Outcomes Research) study is one of the most known cases where researchers ignored safety risks. The study aimed to examine if a new drug Vioxx, produced by drug maker Merck, would cause fewer gastrointestinal side effects for the treatment of the rheumatoid arthritis than naproxen. Over 8,000 patients participated in the study, half of them taking Vioxx, and the other half naproxen. As it turned out, the risk of serious heart problems and death was twice as higher for patients using Vioxx, than for those using naproxen, however, the study decided to ignore the risks and obscure the results.'"`UNIQ--ref-00000535-QINU`"''"`UNIQ--ref-00000536-QINU`"' Five years after Vioxx’s launch, Merck withdrew the drug from the market, but by that time it had already sold billions of dollars of the drug'"`UNIQ--ref-00000537-QINU`"'. Another study published in the medical journal Lancet estimates that 88,000 Americans had heart attacks from taking Vioxx, and 38,000 of them died.'"`UNIQ--ref-00000538-QINU`"'</br>'"`UNIQ--references-00000539-QINU`"'NU`"' '"`UNIQ--references-00000539-QINU`"')
